socalTECH

AUGUST 2, 2010

One of the portfolio firms of San Diego venture capital firm Enterprise Partners is heading towards an IPO, according to a S-1 filing Friday. Enterprise has been an investor in Complete Genomics since 2006, when it was a Series A investor in the firm.

Enterprise Partners 150

Enterprise Partners Venture Capital San Diego Acquisition 150

socalTECH

NOVEMBER 10, 2010

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Enterprise Partners owns about 14.8 According to a filing from Complete Genomics, it will sell 6 million shares at $9.00

Enterprise Partners 124

Enterprise Partners Marketing San Diego Acquisition 124

socalTECH

OCTOBER 14, 2013

Celladon is backed by Enterprise Partners, Pfizer, Lundbeckfond, Novartis Bioventures, J&J Development, GBS Bioventures, MPM Capital, Venrock, H&Q, as well as others. celladon merger acquisition cldn biotech lifescience enzyme heart failure disease' READ MORE>>.

Enterprise Partners 157

Enterprise Partners San Diego Acquisition Capital 157

socalTECH

AUGUST 23, 2013

Financial details of the acquisition were not announced. PathCentral had been venture backed by Arboretum Ventures, Baird Venture Partners, and Okapi Venture Capital. XIFIN''s investors include Boulder Ventures, Enterprise Partners, and Windward Ventures. READ MORE>>.

Windward 138

Windward Enterprise Partners San Diego Acquisition 138

socalTECH

NOVEMBER 2, 2010

It's unclear if the new equity comes as funding from the firm's investors, or if the new equity might be related to the firm's acquisition earlier in October of Broadband Enterprise (BBE), an online video advertising company. Tags: specific media internet advertising merger acquisition. READ MORE>>.

Enterprise Partners 140

Enterprise Partners Advertising Equity Media 140

socalTECH

JULY 30, 2014

XIFIN''s backers include Boulder Ventures, Enterprise Partners, and Windward Ventures. xifin gtcr merger acquisition private equity software saas healthcare molecular diagnostics cloud' GTCR said the investment came from its $3.85 billion GTCR Fund XI, with additional funding provided by GE Capital and CapitalSource.

Windward 138

Windward SaaS Enterprise Partners Equity 138

socalTECH

JUNE 30, 2010

Pappas & Associates, BB Biotech Ventures, CDIB Ventures, CDP Capital Technology Ventures, Chicago Growth Partners, CTI Life Sciences Fund, Enterprise Partners, Forward Ventures, H&Q Investments, Innovis Investments, Pappas Ventures, VantagePoint Venture Partners, and William Blair Capital Partners.

Enterprise Partners 140

Enterprise Partners San Diego Acquisition Pricing 140